...
【24h】

A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2

机译:一种新型的生物相容性输送支架,包含肝素和骨形态发生蛋白2

获取原文
获取原文并翻译 | 示例
           

摘要

Silicon-substituted calcium phosphate (Si-CaP) was developed in our laboratory as a biomaterial for delivery in bone tissue engineering. It was fabricated as a 3D-construct of scaffolds using chitosan-trisodium polyphosphate (TPP) cross-linked networks. In this study, heparin was covalently bonded to the residual -NH2 groups of chitosan on the scaffold applying carbodiimide chemistry. Bonded heparin was not leached away from scaffold surfaces upon vigorous washing or extended storage. Recombinant human bone morphogenetic protein 2 (rhBMP-2) was bound to conjugated scaffolds by ionic interactions between the negatively charged SO(4)(2-)clusters of heparin and positively charged amino acids of rhBMP-2. The resulting scaffolds were inspected for bone regenerative capacity by subcutaneous implanting in rats. Histological observation and mineralization assay were performed after 4 weeks of implantation. Results from both in vitro and in vivo experiments suggest the potential of the developed scaffolds for bone tissue engineering applications in the future.
机译:硅取代的磷酸钙(Si-CaP)是在我们的实验室中开发的,是一种用于在骨组织工程中输送的生物材料。使用壳聚糖-聚磷酸三钠(TPP)交联网络将其制成3D支架结构。在这项研究中,肝素通过碳二亚胺化学共价键合到支架上壳聚糖的残留-NH2基团。剧烈洗涤或长时间存放后,粘结的肝素未从支架表面浸出。重组人骨形态发生蛋白2(rhBMP-2)通过肝素的带负电的SO(4)(2-)簇与rhBMP-2的带正电的氨基酸之间的离子相互作用结合到共轭支架上。通过大鼠皮下植入检查所得支架的骨再生能力。植入4周后进行组织学观察和矿化测定。体外和体内实验的结果表明,将来开发的支架在骨组织工程应用中具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号